纳指生物科技ETF(513290)

动态评分: 5.70分

投资组合

报告日期 名称 比例
2024-06-30 赛诺菲 1.42%
2024-06-30 Medpace Holdings Inc 1.33%
2024-06-30 Viatris Inc 1.31%
2024-06-30 Royalty Pharma plc-A 1.24%
2024-06-30 Insmed Inc 1.12%
2024-06-30 Vaxcyte Inc 0.85%
2024-06-30 Ascendis Pharma AS ADR 0.82%
2024-06-30 BioNTech SE ADR 0.82%
2024-06-30 Roivant Sciences Ltd 0.81%
2024-06-30 Intra-Cellular Therapies Inc 0.75%
2024-06-30 Ionis Pharmaceuticals Inc 0.72%
2024-06-30 爵士制药 0.7%
2024-06-30 Blueprint Medicines Corp 0.7%
2024-06-30 奥洛兹美医疗 0.69%
2024-06-30 伊克力西斯 0.68%
2024-06-30 Revolution Medicines Inc 0.67%
2024-06-30 Cytokinetics Inc 0.65%
2024-06-30 百济神州 0.63%
2024-06-30 Madrigal Pharmaceuticals Inc 0.62%
2024-06-30 Summit Therapeutics Inc 0.57%

投资模拟

公告&资料